share_log

康希诺(688185.SH):就猴痘疫苗的开发,公司已完成抗原初步筛选等前期工作

Cansino Biologics Inc. (688185.SH): in regards to the development of smallpox vaccines, the company has completed preliminary work such as antigen screening.

Gelonghui Finance ·  Aug 16 06:52

On August 16th, Gelunhui reported that Cansino Biologics Inc. (688185.SH) has completed preliminary work such as antigen screening for the development of monkeypox vaccines. The current technology platform has the potential and capability of rapid development and preparation of monkeypox vaccines. The company will continue to monitor the progress of monkeypox outbreaks and carry out related work according to the development plan, funds, and future market space.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment